3,842 5,227 339 20 137 -86 195 102 134% -34% 9% 91% 57% 43% 1Q2020 1Q2019 4Q2019 253 215 239 Operating Performance Exhibit 1: Consolidated Company’s Performance comparison of 1Q2020 vs. 1Q2019 vs. 4Q2019

the approval of the Company’ s Board of Directors on March 27, 2020. P a g e | 18 - Management Discussion and Analysis 2Q2020 - Statement of Cash Flows Exhibit 10 : Consolidated Cash Flows Statement for

specification complies with the government standard. Global Green Chemicals Public Company Limited Management Discussion and Analysis | 3 Operating Performance Exhibit 1: Consolidated Company’s Performance

Section 100 Securities and Exchange Act B.E. 2535 Section 100. The appointment of any person to be an agent or broker of a securities company shall require prior approval from the Office. Application

Performance Exhibit 1: Consolidated Company’s Performance comparison of 4Q2019 vs. 4Q2018 vs. 3Q2019 vs. FY2019 vs. FY2018 Note: (1) Adjusted EBITDA refers to EBITDA excluding impact of Stock Gain/(Loss) and

representative office in the Kingdom shall obtain an approval from the Office. The representative under the first paragraph shall undertake only those businesses specified in the approval. The provisions of

Section 92 Securities and Exchange Act B.E. 2535 Section 92. A securities company may establish a branch office only when an approval has been given by the Office. The application for and the

Commission No. SorKhor. 39/2554 Re: Extension for Period of Approval and Filing Application for Approval of Extension of Personnel in Capital Market Business in Special Circumstances Whereas the first

whole or in part, to manage the business of the securities company only with the approval from the Office. In cases where it later appears that the persons under the first paragraph have the prohibited

Approval for Investor Contacts In continuation of the Notification of the SEC Office No. SorKhor. 15/2548 Re: Approval for Investor Contacts and Standards of Conduct dated 21 June 2005 as amended by the